Secreted Frizzled 연관 단백계 유전자 다형성과 순환계 Osteoprotegerin (OPG) - 용질성 Receptor Activator of NF-kB Ligand (sRANKL) 및 골밀도 사이의 연관성

키워드

참고문헌 (24)

1. NIH Consensus development panel, "Osteoporosis prevention, diagnosis, and therapy", JAMA, 285, pp.785~795 (2001)
2. Jouanny P, "Environmental and genetic factors affecting bone mass. Similarity of bone density among members of healthy families", Arthritis Rheum, 38, pp.61~67 (1995)
3. Gong G, "Association between bone mineral density and candidate genes in different ethnic populations and its implications", Calcif Tissue Int, 72, pp.113~123 (2003)
4. Ralston SH, "Genetics of osteoporosis", Endocr Rev, 31, pp.629~662 (2010)
5. Kim JG, "Association of vitamin D receptor and estrogen receptor gene polymorphisms with bone mass in postmenopausal Korean women", Menopause, 8, pp.222~228 (2001)
6. Kim JG, "The relationship among serum insulin-like growth factor-I, insulin-like growth factor-I gene polymorphism, and bone mineral density in postmenopausal women in Korea", Am J Obstet Gynecol, 186, pp.345~350 (2002)
7. Kim JG, "Association between vitamin D receptor gene haplotypes and bone mass in postmenopausal Korean women", Am J Obstet Gynecol, 189, pp.1234~1240 (2003)
8. Hoeppner LH, "Wnt signaling as a therapeutic target for bone diseases", Expert Opin Ther Targets, 13, pp.485~496 (2009)
9. Johnson ML, "The Wnt signaling pathway and bone metabolism", Curr Opin Rheumatol, 19, pp.376~382 (2007)
10. Westendorf JJ, "Wnt signaling in osteoblasts and bone diseases", Gene, 341, pp.19~39 (2004)
11. Spencer GJ, "Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro", J Cell Sci, 119, pp.1283~1296 (2006)
12. Bovolenta P, "Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease", J Cell Sci, 121, pp.737~746 (2008)
13. Kawano Y, "Secreted antagonists of the Wnt signalling pathway", J Cell Sci, 116, pp.2627~2634 (2003)
14. Sathi GA, "Secreted frizzled related protein (sFRP)-2 inhibits bone formation and promotes cell proliferation in ameloblastoma", Oral Oncol, 45, pp.856~860 (2009)
15. Yao W, "Overexpression of secreted frizzledrelated protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects", J Bone Miner Res, 25, pp.190~199 (2010)
16. Bodine PV, "The Wnt antagonist secreted frizzled-related protein-1 controls osteoblast and osteocyte apoptosis", J Cell Biochem, 96, pp.1212~1230 (2005)
17. Ohnaka K, "Association of single nucleotide polymorphisms in secreted frizzledrelated protein 1 gene with bone mineral density in Japanese women", Geriatr Gerontol Int, 9, pp.304~309 (2009)
18. Sims AM, "Genetic analyses in a sample of individuals with high or low BMD shows association with multiple Wnt pathway genes", J Bone Miner Res, 23, pp.499~506 (2008)
19. 김훈, "Association between polymorphisms in Wnt signaling pathway genes and bone mineral density in postmenopausal Korean women", MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 17(5), pp.1064~1070 (2010), LIPPINCOTT WILLIAMS WILKINS
20. Kanis JA, "The diagnosis of osteoporosis", J Bone Miner Res, 9, pp.1137~1141 (1994)
21. Bennett CN, "Regulation of Wnt signaling during adipogenesis", J Biol Chem, 277, pp.30998~31004 (2002)
22. Cianferotti L, "VDR-mediated inhibition of DKK1 and SFRP2 suppresses adipogenic differentiation of murine bone marrow stromal cells", J Cell Biochem, 101, pp.80~88 (2007)
23. Hausler KD, "Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation", J Bone Miner Res, 19, pp.1873~1881 (2004)
24. Rogers A, "Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment", J Clin Endocrinol Metab, 90, pp.6323~6331 (2005)

관련 논문AI추천